These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 18719091)

  • 1. Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer.
    Ryder M; Ghossein RA; Ricarte-Filho JC; Knauf JA; Fagin JA
    Endocr Relat Cancer; 2008 Dec; 15(4):1069-74. PubMed ID: 18719091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
    Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing outcomes in poorly-differentiated versus anaplastic thyroid cancers treated with radiation: a surveillance, epidemiology, and end results analysis.
    Arora S; Christos P; Pham A; Desai P; Wernicke AG; Nori D; Chao KS; Parashar B
    J Cancer Res Ther; 2014; 10(3):526-30. PubMed ID: 25313732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of hematologic parameters and clinicopathological features of poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.
    Huang D; Zhang J; Zheng X; Gao M
    Langenbecks Arch Surg; 2024 Aug; 409(1):241. PubMed ID: 39105980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Choi HS; Park do J; Jung KC; Sung MW; Kim KH; Hah JH; Park YJ
    Thyroid; 2016 Sep; 26(9):1259-68. PubMed ID: 27412715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poorly differentiated and anaplastic thyroid cancer.
    Patel KN; Shaha AR
    Cancer Control; 2006 Apr; 13(2):119-28. PubMed ID: 16735986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
    Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma.
    Caillou B; Talbot M; Weyemi U; Pioche-Durieu C; Al Ghuzlan A; Bidart JM; Chouaib S; Schlumberger M; Dupuy C
    PLoS One; 2011; 6(7):e22567. PubMed ID: 21811634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference?
    Bichoo RA; Mishra A; Kumari N; Krishnani N; Chand G; Agarwal G; Agarwal A; Mishra SK
    Langenbecks Arch Surg; 2019 Feb; 404(1):45-53. PubMed ID: 30673845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study.
    Cameselle-García S; Abdulkader-Sande S; Sánchez-Ares M; Rodríguez-Carnero G; Garcia-Gómez J; Gude-Sampedro F; Abdulkader-Nallib I; Cameselle-Teijeiro JM
    Oncol Lett; 2021 Jul; 22(1):553. PubMed ID: 34093774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
    Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
    Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of tumor-associated macrophages and BRAF
    Cho JW; Kim WW; Lee YM; Jeon MJ; Kim WG; Song DE; Park Y; Chung KW; Hong SJ; Sung TY
    Head Neck; 2019 Mar; 41(3):686-691. PubMed ID: 30659691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
    Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE
    Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaplastic thyroid cancer in young patients: a contemporary review.
    Li M; Milas M; Nasr C; Brainard JA; Khan MJ; Burkey BB; Scharpf J
    Am J Otolaryngol; 2013; 34(6):636-40. PubMed ID: 23993450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.
    Fang W; Ye L; Shen L; Cai J; Huang F; Wei Q; Fei X; Chen X; Guan H; Wang W; Li X; Ning G
    Carcinogenesis; 2014 Aug; 35(8):1780-7. PubMed ID: 24608042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome.
    Yun JY; Kim YA; Choe JY; Min H; Lee KS; Jung Y; Oh S; Kim JE
    J Clin Pathol; 2014 Feb; 67(2):125-33. PubMed ID: 23986551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.
    Duan H; Li Y; Hu P; Gao J; Ying J; Xu W; Zhao D; Wang Z; Ye J; Lizaso A; He Y; Wu H; Liang Z
    Histopathology; 2019 Dec; 75(6):890-899. PubMed ID: 31230400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma.
    Jung TS; Kim TY; Kim KW; Oh YL; Park DJ; Cho BY; Shong YK; Kim WB; Park YJ; Jung JH; Chung JH
    Endocr J; 2007 Apr; 54(2):265-74. PubMed ID: 17379963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.